Hirtle Callaghan & CO LLC Athersys, Inc Transaction History

Hirtle Callaghan & CO LLC

  • $2.46 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$1.39 - $2.03 $27,799 - $40,599
-20,000 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$1.5 - $2.55 $30,000 - $51,000
20,000
20,000 $41,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Hirtle Callaghan & CO LLC Portfolio

Follow Hirtle Callaghan & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email